Financhill
Sell
42

VNDA Quote, Financials, Valuation and Earnings

Last price:
$4.99
Seasonality move :
92.46%
Day range:
$4.91 - $5.07
52-week range:
$3.71 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.46x
P/B ratio:
0.54x
Volume:
638.1K
Avg. volume:
709.1K
1-year change:
31.05%
Market cap:
$290.4M
Revenue:
$198.8M
EPS (TTM):
-$0.32

Vanda Pharmaceuticals SEC Filings

Company Filed Form Type Description
VNDA
Vanda Pharmaceuticals
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
VNDA
Vanda Pharmaceuticals
11/09/2023 10-Q 10-Q filing on 11/09/2023 View Form
VNDA
Vanda Pharmaceuticals
07/28/2023 10-Q 10-Q filing on 07/28/2023 View Form
VNDA
Vanda Pharmaceuticals
05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
VNDA
Vanda Pharmaceuticals
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
VNDA
Vanda Pharmaceuticals
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
VNDA
Vanda Pharmaceuticals
05/06/2022 10-Q 10-Q filing on 05/06/2022 View Form
VNDA
Vanda Pharmaceuticals
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
VNDA
Vanda Pharmaceuticals
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
VNDA
Vanda Pharmaceuticals
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
VNDA
Vanda Pharmaceuticals
10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
VNDA
Vanda Pharmaceuticals
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
VNDA
Vanda Pharmaceuticals
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
VNDA
Vanda Pharmaceuticals
02/26/2020 10-K 10-K filing on 02/26/2020 View Form
VNDA
Vanda Pharmaceuticals
11/07/2019 10-Q 10-Q filing on 11/07/2019 View Form
VNDA
Vanda Pharmaceuticals
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
VNDA
Vanda Pharmaceuticals
05/03/2019 10-Q 10-Q filing on 05/03/2019 View Form
VNDA
Vanda Pharmaceuticals
02/19/2019 10-K 10-K filing on 02/19/2019 View Form
VNDA
Vanda Pharmaceuticals
11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
VNDA
Vanda Pharmaceuticals
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
VNDA
Vanda Pharmaceuticals
05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
VNDA
Vanda Pharmaceuticals
02/15/2018 10-K 10-K filing on 02/15/2018 View Form
VNDA
Vanda Pharmaceuticals
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
VNDA
Vanda Pharmaceuticals
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
VNDA
Vanda Pharmaceuticals
05/03/2017 10-Q 10-Q filing on 05/03/2017 View Form
VNDA
Vanda Pharmaceuticals
02/17/2017 10-K 10-K filing on 02/17/2017 View Form
VNDA
Vanda Pharmaceuticals
11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
VNDA
Vanda Pharmaceuticals
07/28/2016 10-Q 10-Q filing on 07/28/2016 View Form
VNDA
Vanda Pharmaceuticals
05/05/2016 10-Q 10-Q filing on 05/05/2016 View Form
VNDA
Vanda Pharmaceuticals
02/12/2016 10-K 10-K filing on 02/12/2016 View Form
VNDA
Vanda Pharmaceuticals
11/04/2015 10-Q 10-Q filing on 11/04/2015 View Form
VNDA
Vanda Pharmaceuticals
07/31/2015 10-Q 10-Q filing on 07/31/2015 View Form
VNDA
Vanda Pharmaceuticals
06/10/2015 10-K 10-K filing on 06/10/2015 View Form
VNDA
Vanda Pharmaceuticals
05/07/2015 10-Q 10-Q filing on 05/07/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock